Related Experiment Video
Updated: May 17, 2026

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
Dugbe virus ovarian tumour domain interferes with ubiquitin/ISG15-regulated innate immune cell signalling
S Bakshi1,2, B Holzer1, A Bridgen2
1Institute for Animal Health, Ash Road, Pirbright, Surrey GU24 0NF, UK.
Abstract:
The ovarian tumour (OTU) domain of the nairovirus L protein has been shown to remove ubiquitin and interferon-stimulated gene 15 protein (ISG15) from host cell proteins, which is expected to have multiple effects on cell signalling pathways. We have confirmed that the OTU domain from the L protein of the apathogenic nairovirus Dugbe virus has deubiquitinating and deISGylating activity and shown that, when expressed in cells, it is highly effective at blocking the TNF-α/NF-κB and interferon/JAK/STAT signalling pathways even at low doses. Point mutations of the catalytic site of the OTU [C40A, H151A and a double mutant] both abolished the ability of the OTU domain to deubiquitinate and deISGylate proteins and greatly reduced its effect on cell signalling pathways, confirming that it is this enzymic activity that is responsible for blocking the two signalling pathways. Expression of the inactive mutants at high levels could still block signalling, suggesting that the viral OTU can still bind to its substrate even when mutated at its catalytic site. The nairovirus L protein is a very large protein that is normally confined to the cytoplasm, where the virus replicates. When the OTU domain was prevented from entering the nucleus by expressing it as part of the N-terminal 205 kDa of the viral L protein, it continued to block type I interferon signalling, but no longer blocked the TNF-α-induced activation of NF-κB.
Insights
The nairovirus OTU domain removes ubiquitin and ISG15, effectively blocking TNF-α/NF-κB and interferon/JAK/STAT signaling. This enzymatic activity is crucial for inhibiting these pathways, though substrate binding persists even in inactive mutants.
Area of Science:
- Virology
- Molecular Biology
- Cellular Signalling
Background:
- Nairovirus L protein possesses an ovarian tumour (OTU) domain with deubiquitinating and deISGylating activity.
- This activity is predicted to influence host cell signalling pathways.
Purpose of the Study:
- To confirm the deubiquitinating and deISGylating activity of the Dugbe virus OTU domain.
- To investigate the impact of this activity on TNF-α/NF-κB and interferon/JAK/STAT signalling pathways.
- To elucidate the role of the catalytic site in these inhibitory effects.
Main Methods:
- Expression of the Dugbe virus OTU domain in cells.
- Introduction of point mutations in the catalytic site (C40A, H151A, double mutant).
- Assessment of deubiquitination and deISGylation activity.
- Analysis of TNF-α/NF-κB and interferon/JAK/STAT pathway activation.
- Subcellular localization studies by expressing mutated OTU domains.
Main Results:
- The Dugbe virus OTU domain exhibits significant deubiquitinating and deISGylating activity.
- The OTU domain effectively blocks TNF-α/NF-κB and interferon/JAK/STAT signalling pathways.
- Mutations in the catalytic site abolish enzymatic activity and reduce pathway inhibition.
- Inactive OTU mutants retain substrate binding capability.
- Nuclear localization of the OTU domain is required for blocking TNF-α-induced NF-κB activation, but not for blocking type I interferon signalling.
Conclusions:
- The enzymatic activity of the nairovirus OTU domain is essential for blocking TNF-α/NF-κB and interferon/JAK/STAT signalling.
- Substrate binding by the OTU domain can occur independently of its catalytic activity.
- The subcellular localization of the OTU domain influences its specific inhibitory effects on distinct signalling pathways.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Experimental RNAi
Cancer Cell Migration through Invadopodia

